LY3502970
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for LY3502970, covering 2023-09-13 to 2026-07-17. Get the full timeline:
Most recent: Clinical Trial Results: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]